Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy for Painful Non-Spine Bone Metastases (NCT06391242)
A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases
🩺 Plain-English Summary (8th-Grade Level)
This study is being done to answer the following question: Is Stereotactic Body Radiation Therapy or SBRT (a form of radiation therapy which can deliver high doses of radiation to the specific painful area of the body most affected by cancer, while keeping the radiation beams away from the healthy parts of the body that surround the cancer) better for pain relief than the standard treatment of conventional radiation therapy or CRT (a form of radiation therapy which delivers radiation to the painful area but can also negatively affect other parts of the body in the same area)
Who can join: Review the eligibility criteria below.
Location: Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Age range: 18 Years
🧪 Interventions in This Study
- Standard Conventional Radiotherapy (RADIATION)
- Stereotactic Body Radiotherapy (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
- BCCA - Vancouver — Vancouver, British Columbia
- Juravinski Cancer Centre at Hamilton Health Sciences — Hamilton, Ontario
- Kingston Health Sciences Centre — Kingston, Ontario
- London Health Sciences Centre Research Inc. — London, Ontario
- Stronach Regional Health Centre at Southlake — Newmarket, Ontario
- Odette Cancer Centre — Toronto, Ontario
- University Health Network — Toronto, Ontario
- CIUSSS de l'Est-de-I'lle-de-Montreal — Montreal, Quebec
- CHUM-Centre Hospitalier de l'Universite de Montreal — Montreal, Quebec
- Hotel-Dieu de Quebec — Québec, Quebec
📞 Contact the Study Coordinator
Phone: (613) 533-6430
Email: wparulekar@ctg.queensu.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer Metastatic
- Lay Coach-Led Early Palliative Care for Underserved Advanced Cancer Caregivers: The Project ENABLE Cornerstone RCT — Birmingham, Alabama
- Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers — Tucson, Arizona
- IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures — Boston, Massachusetts
- Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer — Paramus, New Jersey
Explore by condition: All Cancer Metastatic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.